Arcus Biosciences
RCUS
RCUS
75 hedge funds and large institutions have $235M invested in Arcus Biosciences in 2019 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 33 increasing their positions, 19 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
75
Holders Change
-3
Holders Change %
-3.85%
% of All Funds
1.65%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
8
Increased
33
Reduced
19
Closed
10
Calls
–
Puts
$1K
Net Calls
-$1K
Net Calls Change
-$1K
Top Buyers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CSS
76
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$163K | -20,494 | Closed |
|
|
AC
77
Athanor Capital
New York
| – | -$126K | -15,900 | Closed |
|
|
ECM
78
ExodusPoint Capital Management
New York
| – | -$102K | -12,784 | Closed |
|
79
Canada Life
Winnipeg,
Manitoba, Canada
| – | -$39K | -4,956 | Closed |
|
|
AG
80
Aperio Group
Sausalito,
California
| – | -$32K | -3,999 | Closed |
|
81
US Bancorp
Minneapolis,
Minnesota
| – | -$23K | -2,891 | Closed |
|
|
PCM
82
Prelude Capital Management
New York
| – | -$17K | -2,198 | Closed |
|